The clinical performance is complex and often involves multiple systemic burdens. Early identification and standardized clinical care are critical to improving prognosis. The diagnosis of the disease requires a combination of clinical performance, imaging inspections, laboratory tests and pathological evaluation.
The platform can assist in matching a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of the treatment for PML-associated MS requires individual development, typically including pharmacotherapy, rehabilitation interventions, regular follow-up, and multidimensional management. In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many diseases of the nervous system that have previously been difficult to treat have been significantly improved.
Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to the timely schedule according to changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of PML-associated musculoskeletal stenosis. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.